Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
HF Robertson, MJ Buckton & JF Apperley. (2023) Managing women of childbearing age with chronic myeloid leukemia: safety and treatment considerations. Expert Review of Hematology 16:5, pages 325-332.
Read now
Read now
Elena Lorenzi, Matteo Simonelli, Pasquale Persico, Angelo Dipasquale & Armando Santoro. (2021) Risks of molecular targeted therapies to fertility and safety during pregnancy: a review of current knowledge and future needs. Expert Opinion on Drug Safety 20:5, pages 503-521.
Read now
Read now
Articles from other publishers (19)
Ellin Berman. (2023) Family Planning and Pregnancy in Patients with Chronic Myeloid Leukemia. Current Hematologic Malignancy Reports 18:2, pages 33-39.
Crossref
Crossref
Yiyi Luo, Daniel Acevedo, Núria Baños, Andrea Pluma, Raúl Castellanos‐Moreira, Estefania Moreno, Sebastian Rodríguez‐García, Angela Deyà‐Martínez, Ana García‐García, Estefania Quesada‐Masachs, Mireia Torres, Manel Casellas, Dolors Grados, Celia Martí‐Castellote, Jordi Antón, Alexandru Vlagea, Manel Juan, Ana Esteve‐Solé & Laia Alsina. (2023) Expected impact of immunomodulatory agents during pregnancy: A newborn's perspective. Pediatric Allergy and Immunology 34:2.
Crossref
Crossref
艳玲 余. (2023) Current Situation of Bosutinib in the Treatment of Chronic Myeloid Leukemia. Advances in Clinical Medicine 13:01, pages 88-93.
Crossref
Crossref
Darshan Mehta, Miao Li, Noriko Nakamura, Mani Chidambaram, Xiaobo He, Matthew S. Bryant, Ralph Patton, Kelly Davis & Jeffrey Fisher. (2022) In vivo pharmacokinetic analyses of placental transfer of three drugs of different physicochemical properties in pregnant rats. Reproductive Toxicology 111, pages 194-203.
Crossref
Crossref
Elena Inzoli, Andrea Aroldi, Rocco Piazza & Carlo Gambacorti‐Passerini. (2022) Tyrosine Kinase Inhibitor discontinuation in Chronic Myeloid Leukemia: eligibility criteria and predictors of success. American Journal of Hematology 97:8, pages 1075-1085.
Crossref
Crossref
Jinfu Peng, Mayur K. Ladumor & Jashvant D. Unadkat. (2022) Estimation of Fetal-to-Maternal Unbound Steady-State Plasma Concentration Ratio of P-Glycoprotein and/or Breast Cancer Resistance Protein Substrate Drugs Using a Maternal-Fetal Physiologically Based Pharmacokinetic Model. Drug Metabolism and Disposition 50:5, pages 613-623.
Crossref
Crossref
Elisabetta Abruzzese, Stefano Aureli, Francesco Bondanini, Mariavita Ciccarone, Elisabetta Cortis, Antonello Di Paolo, Cristina Fabiani, Sara Galimberti, Michele Malagola, Alessandra Malato, Bruno Martino, Malgorzata Monika Trawinska, Domenico Russo & Paolo de Fabritiis. (2022) Chronic Myeloid Leukemia and Pregnancy: When Dreams Meet Reality. State of the Art, Management and Outcome of 41 Cases, Nilotinib Placental Transfer. Journal of Clinical Medicine 11:7, pages 1801.
Crossref
Crossref
Dan Ran Castillo, Daniel Park, Akhil Mehta, Simmer Kaur, Anthony Nguyen & Mojtaba Akhtari. (2022) Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review. Hematology Reports 14:1, pages 45-53.
Crossref
Crossref
Anupama Rambhatla, Michael R. Strug, Jessica Garcia De Paredes, Marcos I. Cordoba Munoz & Mili Thakur. (2021) Fertility considerations in targeted biologic therapy with tyrosine kinase inhibitors: a review. Journal of Assisted Reproduction and Genetics 38:8, pages 1897-1908.
Crossref
Crossref
Z Topal Suzan, L Tumkaya, T Mercantepe, M Atak & HA Uydu. (2020) The effect of imatinib administered in the prenatal period on testis development in rats. Human & Experimental Toxicology 40:4, pages 634-648.
Crossref
Crossref
Massimo Breccia, Elisabetta Abruzzese, Mario Annunziata, Luigia Luciano & Simona Sica. (2021) Clinical and Psychological Factors to Consider in Achieving Treatment-Free Remission in Patients With Chronic Myeloid Leukemia. Frontiers in Oncology 11.
Crossref
Crossref
Elisabetta Abruzzese & Jane F. Apperley. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia
227
244
.
Jorge E Cortes, Carlo Gambacorti-Passerini, Michael Deininger, Elisabetta Abruzzese, Liza DeAnnuntis & Tim H Brümmendorf. (2020) Pregnancy outcomes in patients treated with bosutinib. International Journal of Hematologic Oncology 9:2.
Crossref
Crossref
Elisabetta Abruzzese, Michael Mauro, Jane Apperley & Ekaterina Chelysheva. (2020) Tyrosine kinase inhibitors and pregnancy in chronic myeloid leukemia: opinion, evidence, and recommendations. Therapeutic Advances in Hematology 11, pages 204062072096612.
Crossref
Crossref
Michael J Reff, Alexandra Shillingburg, Bhavesh Shah, Christopher Elder, Hillary Prescott & Julie Kennerly-Shah. (2019) Front-line use of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia: Practice considerations. Journal of Oncology Pharmacy Practice 26:1, pages 156-174.
Crossref
Crossref
Naomi Eastwood‐Wilshere, Jessica Turner, Niara Oliveira & Adam Morton. (2019) Cancer in Pregnancy. Asia-Pacific Journal of Clinical Oncology 15:6, pages 296-308.
Crossref
Crossref
Ekaterina Chelysheva & Anna Turkina. (2019) Risks and challenges of CML management during pregnancy: Looking for a balanced decision. European Journal of Haematology 102:4, pages 378-379.
Crossref
Crossref
Ekaterina Yur'evna Chelysheva, A.G. Turkina, E.S. Polushkina, M.A. Vinogradova & R.G. Shmakov. (2019) Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations). Clinical oncohematology 12:2, pages 102-110.
Crossref
Crossref
Nicholas Thomas, John Glod, Claudia Derse-Anthony, Emma L. Baple, Nigel Osborne, Rachel Sturley, Bijay Vaidya, Kate Newbold & Antonia Brooke. (2018) Pregnancy on vandetanib in metastatic medullary thyroid carcinoma associated with multiple endocrine neoplasia type 2B. Clinical Endocrinology 88:5, pages 754-756.
Crossref
Crossref